Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Takara Bio Inc. ( (JP:4974) ) just unveiled an announcement.
Takara Bio Inc. announced a resolution to distribute dividends from surplus, maintaining a dividend of ¥17.00 per share for the fiscal year ended March 31, 2025. This decision aligns with the company’s policy of returning profits to shareholders while ensuring sufficient reserves for ongoing research and development, reflecting a payout of approximately 116% of the expected net income.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen1000.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. operates in the biotechnology industry, focusing on the development and commercialization of products and services related to genetic research and biotechnology applications. The company is known for its contributions to life sciences and healthcare, with a market focus on innovative research and development.
Average Trading Volume: 341,122
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen99.58B
For an in-depth examination of 4974 stock, go to TipRanks’ Stock Analysis page.